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Abstract
Background: Dengue virus (DENV), a mosquito borne flavivirus is an important pathogen causing
more than 50 million infections every year around the world. Dengue diagnosis depends on
serology, which is not useful in the early phase of the disease and virus isolation, which is laborious
and time consuming. There is need for a rapid, sensitive and high throughput method for detection
of DENV in the early stages of the disease. Several real-time PCR assays have been described for
dengue viruses, but there is scope for improvement. The new generation TaqMan Minor Groove
Binding (MGB) probe approach was used to develop an improved real time RT-PCR (qRT-PCR)
for DENV in this study.
Results: The 3'UTR of thirteen Indian strains of DENV was sequenced and aligned with 41
representative sequences from GenBank. A region conserved in all four serotypes was used to
target primers and probes for the qRT-PCR. A single MGB probe and a single primer pair for all
the four serotypes of DENV were designed. The sensitivity of the two step qRT-PCR assay was10
copies of RNA molecules per reaction. The specificity and sensitivity of the assay was 100% when
tested with a panel of 39 known positive and negative samples. Viral RNA could be detected and
quantitated in infected mouse brain, cell cultures, mosquitoes and clinical samples. Viral RNA could
be detected in patients even after seroconversion till 10 days post onset of infection. There was no
signal with Japanese Encephalitis (JE), West Nile (WN), Chikungunya (CHK) viruses or with
Leptospira, Plasmodium vivax, Plasmodium falciparum and Rickettsia positive clinical samples.
Conclusion: We have developed a highly sensitive and specific qRT-PCR for detection and
quantitation of dengue viruses. The assay will be a useful tool for differential diagnosis of dengue
fever in a situation where a number of other clinically indistinguishable infectious diseases like
malaria, Chikungunya, rickettsia and leptospira occur. The ability of the assay to detect DENV-2 in
inoculated mosquitoes makes it a potential tool for detecting DENV in field-caught mosquitoes.
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Dengue virus (DENV) is a mosquito borne flavivirus with
four serotypes DENV-1 to 4. The global prevalence of den-
gue has grown dramatically in the recent decades. The dis-
ease is now endemic in more than 100 countries around
the globe and it is estimated that DENV causes 50 to 100
million cases of acute febrile disease every year [1]. Since
1945, outbreaks of dengue caused by all 4 serotypes have
been reported regularly from different regions of India [2].
Dengue is diagnosed by either detecting virus or antibody
to the virus in blood. Isolation of virus in cell culture or in
infant mouse brain remains the gold standard for diagno-
sis, but it takes more than a week for the test to be com-
pleted making it impractical in most situations. Detection
of anti-dengue IgM and IgG in the serum by ELISA is the
most commonly used criteria for presumptive diagnosis
of DENV infections. These serological methods are unable
to detect the infection during the early phase of the dis-
ease. Thus there is a need for rapid and sensitive methods
for detection of DENV early in the course of infection for
better patient management. Several PCR based methods
for detecting DENV nucleic acid in the serum have been
reported, the most widely used test is the nested RT-PCR
developed by Lanciotti et al., [3] and a modification of the
same method to single tube format by Harris et al., [4].
More recently real-time PCR based methods have been
reported for detection and serotyping of DENV which use
fluorescent based reporter chemistries [5-8]. Real-time
PCR has many advantages over conventional RT-PCR, in
that it is more sensitive, can be automated thereby ena-
bling high throughput screening, and the hands on time
including sample handling is less than four hours. The
real-time PCR is also used to quantitate the viral load in
blood samples, making it a useful tool to investigate the
role of viremia in pathogenesis of dengue. Another impor-
tant aspect of dengue disease is the surveillance of vector
population and detection of DENV in field caught mos-
quitoes. Real-time PCR because of its high sensitivity
could be useful in such surveillance and provide early
warning of a possible outbreak of the disease. Recent
reports on DENV group specific real-time PCR used SYBR
green based method [9,10] where as an earlier report
based on TaqMan probes used multiple probe primer sets
for detection of all four serotypes of DENV [11]. In the
present study, we describe the development of a DENV-
specific TaqMan based real-time PCR for detection and
quantitation of all four serotypes using a single probe
primer set targeted against the 3'UTR of DENV.
Methods
Viruses
Sixteen strains of dengue viruses, including five strains of
DENV-1, four strains of DENV-2, three strains of DENV-3,
four strains of DENV-4 and one strain each of JE, WN and
CHK viruses were obtained from the virus repository of
National Institute of Virology, Pune, India, (NIV) as infec-
tious mouse brain stocks (Table 1). DENV stocks were
used directly for sequencing and for evaluation of sensitiv-
ity of the real-time PCR. JE, WN and CHK viruses were
used to evaluate the specificity of the assay.
Infection and maintenance of cell cultures
Vero cells were maintained in MEM supplemented with
10% FCS. One strain of each serotype was amplified in
Vero cells to make virus stocks for determining standard
curves. Cell cultures were infected at 0.1 multiplicity of
infection (MOI) with DENV-1 (16007), DENV-2
(803347), DENV-3 (059826) or DENV-4 (642069). The
virus was harvested after 4 to 5 days post infection after
appearance of cytopathic effect. The infected cell cultures
were subjected to a single freeze thaw. The cell lysates were
clarified by centrifugation at 2000 rpm and stored in suit-
able aliquots at -80°C until used.
Infection of mosquitoes
Female Aedes aegypti mosquitoes were inoculated with 103
PFU/mL of DENV-2 (803347) by intrathoracic route.
Infected mosquitoes were kept for 14 days at 28°C and
80–90% humidity. Surviving mosquitoes were frozen at -
Table 1: Viruses used in the study
Serotype Strain Year and location
DENV-1 623993* 1962, Vellore, India
631287* 1963, Vellore, India
631289* 1963, Vellore, India
055290* 2005, Pune, India
16007@ Thailand
DENV-2 P23085* 1960, Vellore, India
803347*@ 1980, Kolkata, India
939548* 1993, Pune, India
057561* 2005, Pune, India
DENV-3 633798 (H87) Rockefeller lab, USA
059827*@ 2005, Kolkata, India
059826* 2005, Kolkata, India
DENV-4 611318* 1961, Vellore, India
624000* 1962, Vellore, India
631306* 1963, Vellore, India
642069@ 1964, Vellore, India
JEV P20778 1958, Vellore, India
WNV E101 1950, Cairo, Egypt
CHK 62736 2006, Andhra Pradesh, India
*Strains used to sequence 3' UTR for designing primers and probe in 
this study.
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rescence Assay (IFA) as described earlier [12] and the bod-
ies were used for RNA extraction. A total of 34 mosquitoes
including 10 control mosquitoes and 24 mosquitoes
inoculated with DENV-2, were tested by IFA and qRT-
PCR.
Clinical samples
Three hundred and eight blood samples were used to eval-
uate the usefulness of the qRT-PCR assay for its diagnostic
potential. The blood samples were obtained within 10
days post onset of symptoms. The sera were separated,
aliquoted and stored at -80°C. All samples were tested for
presence of DENV RNA by nested RT-PCR as described
earlier [3] and dengue specific IgM antibodies using the
NIV MAC-ELISA kit [13]. Serum samples positive for other
febrile illnesses i.e. Leptospira (n = 2), Rickettsia (n = 1),
and Malaria (n = 2) were provided by Dr. RR. Gadia of
King Edward Memorial Hospital, Pune India. Paired
serum samples (n = 4), which were confirmed to be den-
gue by a four fold rise in HI titre [14] were also included
to analyse the sensitivity of the qRT-PCR. Serum samples
from acute cases of CHK and JE were not available there-
fore sera from healthy individuals were spiked with 105
PFU of CHKV or 103 PFU of JEV and used to evaluate the
specificity of the qRT-PCR.
Primer and probe design
The 3'UTR of four strains of DENV-1 (nt 10230–10700),
four strains of DENV-2 (nt 10301–10708), two strains of
DENV-3 (nt 10243–10689), and three strains of DENV-4
(nt 10315–10635) isolated in India (Table 1) were
sequenced using the big dye terminator kit (Applied Bio-
systems, Foster city, CA, USA). These 13 sequences were
aligned with sequences of 11 DENV-1 strains, 11 DENV-2
strains, 13 DENV-3 strains and 6 DENV-4 strains from
GenBank using the Clustal W programme. A stretch of
nucleotides conserved in the four serotypes was identified
and the primers and probe sequences were designed using
the Primer Express software.
Generation of RNA standard for the qRT-PCR
The target region from the 3'UTR was amplified from
DENV-3 (633798) and cloned in to the TEasy cloning vec-
tor (Promega Corporation, Madison, WI, USA). The pres-
ence and orientation of the insert DNA was confirmed by
sequencing. The plasmid was linearized by digestion with
ApaI and the target sequence was amplified using the in
vitro RNA transcription kit (Roche Diagnostics, IN, USA).
The transcribed RNA was treated with DNAse to digest the
plasmid and purified using the QIAamp RNA purification
kit (Qiagen Sciences, Valencia, CA, USA). The RNA was
quantified by spectrophotometry. The copy numbers of
the RNA was calculated based on the concentration and its
molecular weight and 10 fold serial dilutions of this RNA
from 102 to 108 copies per reaction was used as standard
in all qRT-PCRs.
qRT-PCR
RNA from 140 μl of 10% mouse brain suspension, cell
culture lysate or human serum samples was extracted
using the QIAamp viral RNA extraction kit (Qiagen Sci-
ences, Valencia, CA, USA) as per the manufacturer's pro-
tocol. The RNA was eluted in 60 μl of elution buffer and
stored at -80°C. 10 μL of extracted RNA was used in all
qRT-PCR. In case of mosquitoes, the entire mosquito was
homogenized and the RNA was extracted from the
homogenate using TRIZOL reagent (Invitrogen, Carlsbad,
CA, USA) as per the manufacturer's protocol. The RNA
was resuspended in 20 μl of RNAse free distilled water and
stored at -80°C. 0.5 μL of this RNA was used in the qRT-
PCR. The transcribed or viral RNA was reverse transcribed
using the reverse primer with AMV reverse transcriptase
(Promega Corporation, Madison, WI, USA). The reverse
transcription reaction was carried out at 42°C for 1 h. The
cDNA thus obtained was used as the template in the
qPCR. The TaqMan universal PCR master mix (Applied
Biosystems, Foster city, USA) was used in all qPCRs. Each
reaction had 200 nM of forward primer, 250 nM of probe
and 300 nM of reverse primer in a 25 μL final reaction vol-
ume. The PCR mixtures were pre incubated at 50°C for 2
min followed by denaturation at 95°C for 10 min and 45
cycles of 95°C for 15 sec and 60°C for 1 min using the
Applied Biosystems 7500 real-time PCR system. The real-
time data was analyzed using the SDS software provided
by Applied Biosystems.
Results
Design and evaluation of primers and probes
Alignment of the 3'UTR sequences of 13 Indian strains of
DENV and the 41 sequences from GenBank revealed that
the region was highly conserved within each of the four
serotypes but variable between serotypes. A single stretch
of 100 nucleotides was found to be highly conserved
among the four serotypes of DENV, except for a six base
mismatch in DENV-4. The 100 bp region from nt 10628
to nt 10728 was used to design the primers and probe
(Fig. Fig. 1). A generic reverse primer (nt 10708-10682), a
forward primer (nt 10635–10658) and the probe (nt
10663–10679) were synthesized (Table 2). The probe was
labelled with FAM at the 5'end and a minor groove binder
(MGB) and a non fluorescent quencher at the 3'end.
The specificity of primers and probe were tested against
the four serotypes of DENV, JE, WN, and CHIK viruses.
Fig. 2A shows the amplification plot generated for the dif-
ferent viruses. Amplification of the four serotypes of
DENV was observed from 15 cycles onwards as indicated
by an increase in the fluorescence intensity. The fluores-
cence intensity values for the other viruses remained at thePage 3 of 8
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that the test successfully detected all the four DENV sero-
types but did not show any amplification of JE, WN, and
CHK viruses.
Sensitivity and Specificity of the qRT-PCR assay
RNA extracted from fourteen DENV strains (Table 1)
obtained from the Institute's virus repository and fifteen
serum samples which were confirmed to be positive for
DENV by virus isolation (n = 11) or by a four fold rise in
HI titre in paired serum samples (n = 4) were used to eval-
uate the sensitivity of the qRT-PCR assay. The assay could
detect DENV RNA in all the DENV positive samples indi-
cating that the test was 100% sensitive in detecting DENV
RNA [(number of positive specimens/(number of positive
specimens + number of false negative specimens)].
The specificity of the assay was evaluated using RNA
extracted from virus stocks of two related Flaviviruses (JE
and WN), and CHK virus, which causes a dengue like dis-
ease and is transmitted by the same vector. In addition
RNA extracted from serum samples spiked with JE or CHK
viruses and from sera of confirmed leptospira (n = 2), rick-
ettsia (n = 1) and malaria (n = 2) cases were also used for
determining the specificity of the assay. None of the 10
samples tested by the qRT-PCR assay showed positive
amplification, suggesting that the test was 100% specific
for the detection of DENV [number of negative speci-
mens/(number of negative specimens + number of false
positive specimens)].
The detection limit of the assay was evaluated by both
RNA copy numbers and by PFU. Ten fold serial dilutions
of the in vitro transcribed RNA was used to determine the
sensitivity of the assay. The minimum that could be
detected was 10 copies of RNA molecules per reaction as
indicated in the standard curve (Fig. 2B). For quantitation
by PFU, ten fold dilution of RNA extracted from virus
stocks of all four serotypes of DENV with known PFU tit-
ers were used. The PFU titers of the stock viruses ranged
from 1.3 × 103to 1 × 106/ml (Table 3). The detection limit
of the assay varied for the four serotypes of DENV, the sen-
sitivity of detection was highest for DENV-2 and lowest
for DENV-4 (Fig. Fig. 2C–F, Table 3).
Detection and Quantitation of DENV in human samples
For evaluating the usefulness of the qRT-PCR for detecting
DENV in clinical samples, 308 sera from dengue sus-
pected cases were tested by MAC-ELISA, nested RT-PCR
and qRT-PCR. Of the total samples tested, 212 (68.8%)
were positive for dengue infection by one of the three
methods described. Among the 212 dengue positive cases,
65 (30.7%) were positive for viral RNA by qRT-PCR and
36 (16.9%) by nested RT-PCR. All nested RT-PCR positive
samples were also positive by qRT-PCR. Of the 186 IgM
positive samples 33 (17.7%) were positive for DENV RNA
by qRT-PCR whereas only 15 (8.1%) were positive by
nested RT-PCR. Therefore qRT-PCR was found to be
highly sensitive (p < 0.01, McNemar's test) in detecting
DENV when compared to RT-PCR. The minimum amount
of RNA detected in these samples was 1.04 × 104 copies/
mL and the maximum amount detected was 6.9 × 1012
copies/mL of serum. The mean viremia was higher during
the initial days of infection and decreased during later
stages of infection (Fig. 3). The number of samples posi-
tive by qRT-PCR during 2–5 days post onset of fever (47/
105) was highly significant (p < 0.01, Chi-square test with
Yates correction) when compared with samples collected
from 6–10 days post onset of fever (18/107). The inverse
was true for IgM, where in the detection of IgM was signif-
icantly higher (p < 0.01, Chi-square test with Yates correc-
tion) in the samples collected from 6–10 days post onset
of fever (104/107) when compared to the 2–5 days post
onset of fever (82/105).
Discussion
Several real-time PCR based methods for detection of
DENV have been reported in the last decade. These assays
have targeted the 3'UTR [9,15], NS5 [11,16], core [9] and
Clustal W alignment of the DENV 3'UTR region sequenced by us and representative s quence of each serotype of DENV download d from the gen bankFigure 1
Clustal W alignment of the DENV 3'UTR region 
sequenced by us and representative sequence of each 
serotype of DENV downloaded from the gene bank.
 
Table 2: Nucleotide sequence of primers and probe used in the qRT-PCR assay
Sequence Nucleotide position
Forward Primer 5'-GARAGACCAGAGATCCTGCTGTCT-3' 10635–10658
Reverse Primer 5'-ACCATTCCATTTTCTGGCGTT-3' 10708-10682
TaqMan MGB Probe 5'-AGCATCATTCCAGGCAC-3' 10663–10679Page 4 of 8
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Specificity and sensitivity of the qRT-PCR assayFigure 2
Specificity and sensitivity of the qRT-PCR assay. (A) Amplification plots obtained for DENV-1 to 4 viruses, (B) standard 
curve of the in vitro transcribed RNA and (C-F) standard curves for the four DENV serotypes.
                                  (A)                                                                                                (B) 
         
                                    (C)                                                                                    (D) 
                                             (E)                                                                                      (F) 
Virology Journal 2009, 6:10 http://www.virologyj.com/content/6/1/10the envelope [17] gene sequences. Majority of the recent
reports describe development of the serotype specific real-
time PCR for dengue using TaqMan probes [8,18] or FRET
probes [6]. Though these methods are useful for serotyp-
ing of DENV they may not be cost-effective for routine
diagnosis as only a small percentage of samples are posi-
tive for DENV RNA during the non endemic season and
during the active transmission season only about 50% of
samples may be positive for DENV RNA [6]. A group spe-
cific PCR would be a useful tool for initial screening of the
samples and only those samples positive for DENV can
then be subjected to serotyping. Lai et al., [6] initially
screened samples by a SYBR green based group specific
real-time PCR and then serotyped the positive samples by
a duplex or a fourplex TaqMan based assay, thereby reduc-
ing the operation cost on diagnosis by half. The SYBR
green-based detection systems have the major disadvan-
tage of false positives due to dye binding to primer dimers
or to DNA amplified non-specifically. Melt curve analyses
is often used to confirm the fidelity of the reaction. Other
group specific real time PCR assays reported are also SYBR
green based [9,10,19]. The first DENV group specific assay
using TaqMan probes was described by Callahan et al.,
[11]. In the assay the authors have used multiple probe
primer sets for establishing a group specific RT-PCR assay.
This could have been because of lack of a suitable stretch
of conserved nucleotides for designing the conventional
TaqMan probes, earlier observed by Laue et al., [16]. The
new generation MGB probes can be much shorter in
length because of the Minor groove binder tagged to the
probe, which increases the thermal stability of the probes.
We used the TaqMan MGB probe to develop the group
specific assay in this report which made it possible to use
the short conserved region in the 3'UTR of the dengue
genome to design the assay using a single probe and
primer pair combination. The fluorescent probes in Taq-
Man assay are known to be target specific and sensitive to
mismatches [20]. To avoid false negative results due to
mismatches in the probe binding sites, the 3'UTR region
of thirteen Indian strains, representing all four serotypes,
isolated from different regions in India were sequenced.
These sequences were aligned with representative
sequences of all four serotypes from the GenBank and a
conserved region of 100 nucleotides was used to design
the primers and probe.
All four serotypes of DENV from infected mouse brain or
cell cultures or mosquitoes or clinical samples could be
detected by the qRT-PCR. No amplification with the
related Flaviviruses or with samples from other febrile ill-
ness was observed. The sensitivity of the qRT-PCR in terms
of PFU was highest for DENV-2 at 0.001 PFU followed by
DENV-1 and DENV-3 at 0.01 PFU and DENV-4 had the
lowest sensitivity of 1 PFU. The difference in sensitivity
could have been due to a difference in the proportion of
non-infectious RNA transcripts to infectious particles. The
mismatches between the DENV-4 virus sequence and the
reverse primer could have contributed to the lowest sensi-
tivity of 1 PFU. An alternate reverse primer with DENV-4
sequence can be included to bring the sensitivities at par.
The qRT-PCR assay was able to detect viral RNA in a sig-
nificantly larger number of clinical samples (30.7%) than
RT-PCR (16.9%) (p < 0.001, Mc Nemar's test). The qRT-
PCR also detected DENV RNA in a larger number of IgM
positive samples when compared to the nested RT-PCR.
There is increasing recognition of the importance of viral
burden in the pathogenesis of DHF and a direct associa-
tion between viral load and severity of the disease has
been reported [21-23] In earlier studies on viral load the
method used to quantitate the virus in the blood samples
were either mosquito infectious dose (MID50) or PFU. It
has been difficult to compare any two studies as the meas-
ures vary depending upon the strain of the virus and the
substrate used i.e. mosquito or cell line. None of the
group specific real-time PCRs reported [6,9-11,24] devel-
oped a quantitative RNA standard. We developed an RNA
standard for quantitating DENV RNA in this study. The
RNA copy number, which offers minimum variability,
was used to quantitate the viral load in human clinical
samples. Viremia was found to be higher in the initial
days of the illness decreasing gradually during the later
stages of the infection. This result is consistent with earlier
findings based on mosquito inoculation and serotype spe-
cific real-time PCR [15,25].
An important aspect of dengue disease control is vector
surveillance. Detection of DENV positive mosquitoes will
be useful to monitor the infection rates within vector mos-
quito population and provide an early warning signal to
predict an impending epidemic [26]. Currently IFA, insect
bioassay, ELISA and RT-PCR are the methods available for
Table 3: Detection limit of the qRT-PCR assay for the four serotypes of DENV
Serotype(Strain) Titer PFU/mL Detection limit (PFU) Correlation coefficient
DENV-1 (16007) 1.3 × 103 0.1 0.98
DENV-2 (803347) 4.2 × 106 0.001 0.99
DENV-3 (059826) 1.4 × 104 0.1 0.99
DENV-4 (642069) 3.58105 1 0.99Page 6 of 8
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assay could detect DENV-2 RNA in all the inoculated mos-
quitoes. The sensitivity of detection was such that a 40th
fraction of the infected mosquito body lysate was suffi-
cient to give a positive signal in the qRT-PCR, thus even
low levels of viral RNA in infected mosquitoes should be
detected with the assay. No false positives were observed
with control mosquitoes. However testing of field caught
mosquitoes by the qRT-PCR will prove its usefulness for
vector surveillance.
Conclusion
The group specific real-time PCR developed in this study
will be a useful tool for differential diagnosis of dengue
fever in a situation where a number of other diseases like
malaria, Chikungunya, rickettsia and leptospira co-exist
and are clinically indistinguishable. In areas where other
flaviviruses are circulating, IgM detection is not conclusive
because of cross reactivity that exists between DENV, JEV
and WNV. The ability of the qRT-PCR assay to detect
DENV RNA in seropositive individuals up to 10 days post
onset of fever is an advantage in such situations. The abil-
ity of the assay to detect DENV-2 in inoculated mosqui-
toes makes it a potential tool for detecting DENV in field
caught mosquitoes.
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